Taken together, these results imply that PRMT5 has multiple roles in breast cancer growth, regulating both tumor-initiating and more differentiated cells, and that drug targeting of PRMT5 could potentially affect the survival of both cell populations. The gene discussed is PRMT5; the disease is neoplasm.